首页> 外文期刊>Urologic oncology >Caveolin-1 as prognostic factor of disease recurrence and survival in patients treated with radical cystectomy for bladder cancer
【24h】

Caveolin-1 as prognostic factor of disease recurrence and survival in patients treated with radical cystectomy for bladder cancer

机译:Caveolin-1作为疾病复发和存活的预后因素治疗膀胱切除术治疗膀胱癌

获取原文
获取原文并翻译 | 示例
           

摘要

Purpose: Overexpression of Caveolin-1 has been associated with cancer growth, migration, and metastases in several malignancies, but only few data are available on its role in bladder cancer (BCa). The aim of this study is to validate Caveolin-1 as a prognosticator of recurrence-free survival (RFS), overall survival (OS) and cancer-specific survival (CSS) in a large cohort of patients treated with radical cystectomy (RC) for BCa.
机译:目的:患有癌症生长,迁移和转移的过度表达在几种恶性肿瘤中患有癌症生长,但只有很少的数据可以在膀胱癌(BCA)中的作用。 本研究的目的是将Caveolin-1验证为可复发存活(RFS),总体存活(OS)和癌症特异性生存(CSS)的患者,其大量伴有自由基膀胱切除术(RC)为 BCA。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号